It has been shown that these upregulated hub genes are associated with many cancer risks and may serve as potential biomarkers or therapeutic targets for BC, especially FNI and IL1B, which were upregulated in the expression of both low-grade and high-grade BC cell-derived EVs. The gene discussed is IL1B; the disease is breast cancer.